Gyrodyne (GYRO) Stock Price, News & Analysis

Company Overview

Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.

Key Stats

• Today's Range: $10.67 to $10.67
• 50-Day Range: $8.30 to $10.67
• 52-Week Range: $6.80 to $12.00
• Volume: 883 shs
• Average Volume: 8,755 shs
• Market Capitalization: $23.09 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Gyrodyne Stock Analysis - MarketRank™

Gyrodyne scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Gyrodyne .

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Gyrodyne has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.03% of the float of Gyrodyne has been sold short.

Short Interest Ratio / Days to Cover

Gyrodyne has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Gyrodyne has recently decreased by 28.57%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Gyrodyne does not currently pay a dividend.

Dividend Growth

Gyrodyne does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.03% of the float of Gyrodyne has been sold short.

Short Interest Ratio / Days to Cover

Gyrodyne has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Gyrodyne has recently decreased by 28.57%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Gyrodyne this week, compared to 0 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Gyrodyne insiders have not sold or bought any company stock.

Percentage Held by Insiders

12.10% of the stock of Gyrodyne is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

71.36% of the stock of Gyrodyne is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GYRO Stock Analysis - Frequently Asked Questions

How have GYRO shares performed this year?

Gyrodyne 's stock was trading at $9.02 at the start of the year. Since then, GYRO stock has increased by 16.4% and is now trading at $10.4950.

How do I buy shares of Gyrodyne ?

Shares of GYRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Gyrodyne own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Gyrodyne investors own include Meta Platforms (META), Acasti Pharma (ACST), Amyris (AMRS), Ariad Pharmaceuticals (ARIA), Astrotech (ASTC), Athersys (ATHX) and (AVNR) (AVNR).

Company Calendar

• Today: 8/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: REAL ESTATE OPS
• Sub-Industry: Diversified REITs
• Current Symbol: NASDAQ:GYRO
• CIK: 1589061
• Web: www.gyrodyne.com
• Phone: (631) 584-5400
• Fax: 631-584-7075
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $19.51 per share
• Price / Book: 0.54

Miscellaneous

• Outstanding Shares: 2,200,000
• Free Float: 1,933,000
• Market Cap: $23.09 million
• Optionable: Not Optionable
• Beta: 0.37